Are TTK Healthcare Ltd. latest results good or bad?

Jan 23 2026 07:13 PM IST
share
Share Via
TTK Healthcare Ltd.'s latest Q3 FY26 results show stable revenue growth of 2.23% to ₹209.30 crores, but a concerning 37.06% decline in net profit to ₹10.53 crores, highlighting operational inefficiencies and heavy reliance on non-operating income. Overall, the results indicate significant challenges in profitability despite stable sales.
TTK Healthcare Ltd.'s latest financial results for Q3 FY26 present a complex picture characterized by stable revenue generation but significant challenges in profitability. The company's net sales reached ₹209.30 crores, reflecting a modest year-on-year growth of 2.23% compared to ₹204.74 crores in the same quarter last year. This growth, while positive, is notably lower than the previous year's performance, indicating a struggle to maintain momentum in a competitive market.
However, the company's net profit exhibited a concerning decline, falling to ₹10.53 crores, which represents a year-on-year decrease of 37.06%. This sharp contraction in profit highlights operational inefficiencies, as evidenced by the profit after tax margin compressing to 5.03%, down from 10.02% in the previous quarter. The operating margin, although showing a slight sequential improvement to 3.41%, remains significantly below historical levels, indicating persistent challenges in managing costs effectively. A critical concern for TTK Healthcare is its heavy reliance on non-operating income, which constituted a substantial 80.43% of profit before tax in this quarter. This dependency raises questions about the sustainability of earnings quality, as the core operating profit, excluding other income, was merely ₹7.14 crores. The company's operational performance is further underscored by elevated employee costs and a gross profit margin that has declined significantly compared to the previous year. In terms of evaluation, TTK Healthcare experienced an adjustment in its evaluation, reflecting the ongoing operational challenges and the impact of its financial performance on investor sentiment. The company's return on equity has also seen deterioration, indicating a decline in its ability to generate returns on shareholder capital. Overall, TTK Healthcare's Q3 FY26 results reveal a company facing significant operational hurdles despite achieving stable revenue growth. The reliance on non-operating income and the compression of profit margins suggest that the company must address its core operational inefficiencies to improve its financial health and investor confidence moving forward.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
TTK Healthcare Ltd. is Rated Sell
Feb 02 2026 10:10 AM IST
share
Share Via
TTK Healthcare Ltd. Stock Hits 52-Week Low at Rs.949
Feb 01 2026 10:54 AM IST
share
Share Via
TTK Healthcare Ltd. Stock Falls to 52-Week Low of Rs.954.4
Jan 30 2026 11:04 AM IST
share
Share Via
TTK Healthcare Ltd. Stock Hits 52-Week Low at Rs.954.75
Jan 29 2026 12:16 PM IST
share
Share Via
Why is TTK Healthcare Ltd. falling/rising?
Jan 28 2026 12:44 AM IST
share
Share Via